Skip to content

FDM PHARMA

Absorbed by PHARMACIE de MUNCK FRANCOIS on 09-02-2021 KBO/BCE: BE 0865.948.197

Timeline

31 events since 2004
2021
Annual accounts 2020 filed PDFfull format · 27 days late
Merger: absorbed by PHARMACIE Dissolution of the company · Dissolved without liquidation · Cancellation of 695 shares · General meeting of 21-01-20216 points ▸
  • Incorporation, 11-02-2014
  • General meeting of 21-01-2021
  • Incorporation, 08-06-2004
  • PHARMACIE holds all the shares
  • The operation takes effect in the accounts on 01-01-2021
  • Power of attorney granted to
  • The deed holds 19 more points.

Open the deed in the Belgian Official Gazette

2020
Highest result from 2006 to 2020 net €104,278 ▲32% The operating result of €150,559 and the net result of €104,278 are both a record.
Equity above €200,000 equity €298,269 ▲53.8% After 5 profitable years in a row, equity reaches €298,269.
Demerger proposal: FDM Pharma splits off to PHARMACIE PHARMACIE holds all the shares2 points ▸
  • PHARMACIE holds all the shares
  • Operation treated as a merger by absorption
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2019 filed PDFfull format · 13 days late
2019
Equity above €150,000 equity €193,991 ▲68.7% After 4 profitable years in a row, equity reaches €193,991.
Annual accounts 2018 filed PDFfull format · 36 days before the deadline
2018
Equity above €100,000 equity €115,003 ▲84% After 3 profitable years in a row, equity reaches €115,003.
Annual accounts 2017 filed PDFfull format · 49 days before the deadline
2017
Annual accounts 2016 filed PDFfull format · 47 days before the deadline
2016
Back to profit net €78,604 The net result is €78,604, after 2 loss-making years.
Annual accounts 2015 filed PDFfull format · 22 days late
2015
Weakest financial year net -€40,190 The net result drops to -€40,190, the lowest from 2006 to 2020.
Liquidity more than doubled current ratio 1.09 The current ratio rises from 0.43 to 1.09. Short-term debt falls from €469,990 to €366,921.
Annual accounts 2014 filed PDFfull format · 28 days late
Company renamed from to FDM PHARMACapital increase of €20,088 to €51,708 · The capital rose from €31,620 to €51,708, with 270 new shares · (manager) and (statutory manager) resign · General meeting of 18-03-201514 points ▸
  • General meeting of 18-03-2015
  • holds 1 share
  • PHARMACIE holds 424 shares
  • The capital is divided into 425 shares
  • Name change, FDM PHARMA
  • Net-asset statement, 31-12-2014
  • The capital was increased by €20,088
  • The capital is €51,708, divided into 695 shares
  • resigns as manager
  • Discharge granted to
  • resigns as statutory manager
  • Discharge granted to
  • appointed as manager, not named in the articles
  • PHARMACIE appointed as manager, not named in the articles
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

2014
Annual accounts 2013 filed PDFfull format · 29 days late
2013
Annual accounts 2012 filed PDFfull format · 14 days late
2012
Back to profit net €27,159 The net result is €27,159, after 5 loss-making years.
Annual accounts 2011 filed PDFfull format · 79 days late
2011
Merger: VADIPHAR takes over Company renamed from VADIPHAR to · Capital increase of €13,020 to €31,620 · The capital rose from €18,600 to €31,620, with 175 new shares · General meeting of 30-06-20116 points ▸
  • General meeting of 30-06-2011
  • Merger by absorption
  • The capital was increased by €13,020
  • Name change,
  • Article 1 of the articles of association amended
  • The capital is €31,620, divided into 425 shares
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2010 filed PDFfull format · 17 days late
Restructuring PDFCapital €10,538, annual accounts 2011
2010
Annual accounts 2009 filed PDFfull format · 32 days before the deadline
2009
Annual accounts 2008 filed PDFfull format · 22 days before the deadline
2008
Annual accounts 2007 filed PDFfull format · 42 days before the deadline
2007
Annual accounts 2006 filed PDFfull format · 12 days before the deadline
2006
Annual accounts 2005 filed PDFfull format
2005
Annual accounts 2004 filed PDFfull format
2004
Incorporation PDF12 publications in the Belgian Official Gazette, the last on 09-02-2021

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

Between 2011 and 2015 the capital was increased 2 times, most recently to €51,708.12 The name was changed to FDM PHARMA in 2015.2 In 2021 FDM PHARMA was absorbed by merger into PHARMACIE .3

  1. 1Belgian Official Gazette, 19-08-2011
  2. 2Belgian Official Gazette, 13-04-2015
  3. 3Belgian Official Gazette, 09-02-2021

Mentions of companies taken over

PHARMACIE BOUILLON, the company FDM PHARMA took over in the merger published in the Belgian Official Gazette on 19-08-2011, is named in 3 deeds.
Show the 3 deeds